Generics 72

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Terbinafine manufacturers

72 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

72 products found

terbinafine

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120
This globally competitive organization specializes in formulating a wide range of medications and exports to over 40 countries. Their state-of-the-art manufacturing facilities are strategically located across three cities, adhering to stringent regulatory standards like those set by the EU, UK, and UNICEF. They produce diverse dosage forms including tablets, capsules, creams, ointments, gels, and sterile formulations such as lyophilized products and prefilled syringes. Key therapy areas include complex generics, orphan drugs, and treatments for neglected tropical diseases. The company holds GMP certifications and possesses product patents, emphasizing their commitment to quality and innovation. They actively participate in global initiatives, providing emergency stockpiles for coronavirus treatments and partnering with organizations to address the healthcare needs of Palestinian refugees.

Manufacturer usually replies in 7 days

terbinafine

Tablets 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #12311
This pharmaceutical company specializes in developing and supplying drug products and substances to global markets. Their focus is on innovation and quality, offering both prescription and over-the-counter products. The company boasts strong GMP certifications, ensuring adherence to international standards. Their portfolio likely includes solid dosage forms and may extend to injectables or liquids. While specific therapy areas are not mentioned, the focus on advanced markets suggests specialization in areas like oncology, cardiology, or neurology. With a proven track record of supplying high-quality pharmaceuticals, they likely hold multiple product patents. The company's decades-long presence in the industry, particularly in the European Union and North America, underscores their commitment to global healthcare solutions.

Manufacturer usually replies in 14 days

terbinafine

Oral powder 1 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18859
This company is a global healthcare provider specializing in dermatological and pediatric care products. They offer a wide range of pharmaceuticals, cosmeceuticals, and supplements, including prescription medications, over-the-counter drugs, topical treatments, and oral solutions. Their key therapy areas include anti-acne, skin brightening, antifungal, antibacterial, antiparasitic, anti-hyperkeratosis, immunomodulator, moisturizing, anti-itch, and hair growth solutions. They utilize various dosage forms, such as tablets, gels, soaps, and serums. The company emphasizes quality control and boasts GMP certifications.

Manufacturer usually replies in 7 days

Want to see all 72 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Terbinafine is an antifungal medication pityriasis versicolor, fungal nail infections, tinea capitis, tinea corporis, tinea cruris, tinea pedis, and cutaneous candidiasis. Terbinafine manufacturers produce medications with it as the standalone ingredient, as well as use it in combination drug formulations along with ingredients such as mometasone and urea. Suppliers of terbinafine market it in the form of 125mg and 250mg oral tablets as well as 10mg/g topical creams. The developer and earliest manufacturer of terbinafine was Novartis, who first introduced it into the market under the trade name Lamisil in Europe in 1991, and the U.S. in 1996. Lamisil is currently available in over 70 countries worldwide, including but not limited to Australia, Brazil, Russia, South Africa, Thailand, and many more geographical markets. What is more, following the expiry of the manufacturer’s patent in 2007, other producers and suppliers launched their formulations of the drug into the market. Terbinafine is included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. And it is a widely prescribed drug, with over 1 million prescriptions being registered yearly in the U.S. alone. The global terbinafine market is fragmented, with multiple pharmaceutical companies, from small local manufacturers to large multinational industry players marketing both generic and trade name terbinafine formulations. Among the largest manufacturers and suppliers of terbinafine are well-known names such as Novartis, GlaxoSmithKline, Gedeon Richter, Sun Pharmaceuticals, Teva, Pfizer, and Mylan. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified terbinafine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Costs per 28 (250mg) tablets of terbinafine range from 25 EUR to 30 EUR, whereas 15g (10mg/g) of terbinafine topical cream can cost anywhere from 4,00 EUR to 11,00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible